ReviewUrologic oncology2018

The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1.

Alexander Sankin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.